Detalhe da pesquisa
1.
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS).
Cancer
; 127(23): 4421-4431, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34424530
2.
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021.
J Natl Compr Canc Netw
; 19(1): 16-27, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33406488
3.
The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemia.
Am J Hematol
; 95(9): 1006-1014, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32390196
4.
Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 17(6): 721-749, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31200351
5.
Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study.
Lancet Oncol
; 18(8): 1061-1075, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28645776
6.
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(7): 926-957, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28687581
7.
Secondary-type mutations do not impact prognosis in acute myelogenous leukemia AML with mutated NPM1.
Am J Hematol
; 97(12): E462-E465, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36106410
8.
Unfavorable-risk acute myeloid leukemia dissected.
Curr Opin Hematol
; 23(2): 144-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26825699
9.
Isocitrate dehydrogenase inhibitor-driven differentiation may resemble secondary graft failure in post-allogeneic haematopoietic cell transplantation relapsed acute myeloid leukaemia.
Br J Haematol
; 194(5): 927-931, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34096047
10.
Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study.
Lancet Oncol
; 16(9): 1025-1036, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26234174
11.
Transfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromes.
BMC Genomics
; 16: 727, 2015 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26400237
12.
REVEAL-1, a phase 2 dose regimen optimization study of vosaroxin in older poor-risk patients with previously untreated acute myeloid leukaemia.
Br J Haematol
; 168(6): 796-805, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25403830
13.
Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia.
Haematologica
; 100(9): 1172-9, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26022709
14.
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML.
Leukemia
; 38(1): 58-66, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935977
15.
Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia.
Haematologica
; 103(11): e514-e518, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29794146
16.
Acute myeloid leukemia, version 2.2013.
J Natl Compr Canc Netw
; 11(9): 1047-55, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24029121
17.
Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study.
Lancet Oncol
; 13(11): 1096-104, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23075701
18.
PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis.
Clin Cancer Res
; 29(13): 2375-2384, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036505
19.
NCCN Clinical Practice Guidelines Acute myeloid leukemia.
J Natl Compr Canc Netw
; 10(8): 984-1021, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22878824
20.
Diagnosis and treatment of therapy-related acute myeloid leukemia.
Crit Rev Oncol Hematol
; 171: 103607, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35101585